Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles-Reference-Cited by-同舟云学术

Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles

Published:2014 Issue:1 Volume:12 Page:141-148
ISSN:1477-0520
Container-title:Org. Biomol. Chem.
language:en
Short-container-title:Org. Biomol. Chem.

Author:

Lebraud Honorine,Coxon Christopher R.,Archard Victoria S.,Bawn Carlo M.,Carbain Benoit,Matheson Christopher J.,Turner David M.,Cano Celine,Griffin Roger J.,Hardcastle Ian R.,Baisch Ulrich,Harrington Ross W.,Golding Bernard T.

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2014/OB/C3OB41806E

Reference39 articles.

1. Targeting cancer with small molecule kinase inhibitors

2. Selectively Nonselective Kinase Inhibition: Striking the Right Balance

3. Kinase Drug Discovery – What’s Next in the Field?

4. Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks

5. Chemical genetic strategy for targeting protein kinases based on covalent complementarity

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Requirement of Nek2a and cyclin A2 for Wapl-dependent removal of cohesin from prophase chromatin;The EMBO Journal;2024-09-13

2. Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update;Journal of Medicinal Chemistry;2024-05-07

3. Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices;Molecular Diversity;2022-09-04

4. N-Acylamino Saccharin as an Emerging Cysteine-Directed Covalent Warhead and Its Application in the Identification of Novel FBPase Inhibitors toward Glucose Reduction;Journal of Medicinal Chemistry;2022-07-05

5. Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development;Molecules;2022-01-06